Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.13 USD | +1.23% | +6.02% | +147.90% |
05-09 | Q32 Bio Inc. Provides Corporate Update | CI |
04-11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.90% | 324M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- RBC Cuts Price Target on Homology Medicines to $3 From $4, Maintains Sector Perform, Speculative Risk